D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Emerson Electric
EMR
|
+$577M |
| 2 |
Amazon
AMZN
|
+$538M |
| 3 |
Tesla
TSLA
|
+$501M |
| 4 |
Netflix
NFLX
|
+$352M |
| 5 |
Adobe
ADBE
|
+$342M |
Top Sells
| 1 |
Alibaba
BABA
|
+$945M |
| 2 |
NVIDIA
NVDA
|
+$485M |
| 3 |
CELG
Celgene Corp
CELG
|
+$460M |
| 4 |
ConocoPhillips
COP
|
+$344M |
| 5 |
Biogen
BIIB
|
+$322M |
Sector Composition
| 1 | Technology | 20.59% |
| 2 | Consumer Discretionary | 15.86% |
| 3 | Healthcare | 13.39% |
| 4 | Financials | 10.6% |
| 5 | Industrials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TRQ
1276
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $3.76M | ﹤0.01% |
514,065
+442,726
| +621% | +$3.24M |
|
1277
Lithia Motors
LAD
$8.68B
| $3.75M | ﹤0.01% |
25,535
-46,498
| -65% | -$6.84M |
|
1278
AXIS Capital
AXS
$7.73B
| $3.75M | ﹤0.01% |
63,106
+51,613
| +449% | +$3.07M |
|
1279
Stanley Black & Decker
SWK
$11.9B
| $3.74M | ﹤0.01% |
22,590
-173,703
| -88% | -$28.8M |
|
1280
Citi Trends
CTRN
$278M
| $3.74M | ﹤0.01% |
161,699
+1,335
| +0.8% | +$30.9K |
|
1281
Ingersoll Rand
IR
$31.6B
| $3.72M | ﹤0.01% |
101,446
-452,892
| -82% | -$16.6M |
|
|
CHS
1282
DELISTED
Chicos FAS, Inc.
CHS
| $3.71M | ﹤0.01% |
972,945
+721,269
| +287% | +$2.75M |
|
1283
Roku
ROKU
$13.8B
| $3.7M | ﹤0.01% |
+27,623
| New | +$3.7M |
|
1284
Corbus Pharmaceuticals
CRBP
$114M
| $3.69M | ﹤0.01% |
22,505
-2,132
| -9% | -$349K |
|
1285
Taylor Morrison
TMHC
$6.93B
| $3.69M | ﹤0.01% |
168,553
-374,085
| -69% | -$8.18M |
|
1286
CNX Resources
CNX
$4.24B
| $3.68M | ﹤0.01% |
415,525
+317,470
| +324% | +$2.81M |
|
|
MCHB
1287
Mechanics Bancorp Class A Common Stock
MCHB
$3.01B
| $3.68M | ﹤0.01% |
108,109
+1,875
| +2% | +$63.8K |
|
1288
Martin Marietta Materials
MLM
$37.5B
| $3.67M | ﹤0.01% |
13,128
+5,251
| +67% | +$1.47M |
|
1289
Flotek Industries
FTK
$340M
| $3.65M | ﹤0.01% |
304,263
-6,610
| -2% | -$79.3K |
|
|
BEST
1290
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
| $3.65M | ﹤0.01% |
32,825
-1,141
| -3% | -$127K |
|
|
HOLI
1291
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $3.64M | ﹤0.01% |
221,993
+64,408
| +41% | +$1.06M |
|
|
ODT
1292
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $3.63M | ﹤0.01% |
111,997
+41,913
| +60% | +$1.36M |
|
1293
B2Gold
BTG
$5.91B
| $3.63M | ﹤0.01% |
905,952
-378,493
| -29% | -$1.52M |
|
1294
Kura Oncology
KURA
$726M
| $3.62M | ﹤0.01% |
263,220
+67,322
| +34% | +$926K |
|
1295
WaFd
WAFD
$2.48B
| $3.6M | ﹤0.01% |
98,105
+39,543
| +68% | +$1.45M |
|
1296
Children's Place
PLCE
$149M
| $3.59M | ﹤0.01% |
57,377
-127,803
| -69% | -$7.99M |
|
|
AUY
1297
DELISTED
Yamana Gold, Inc.
AUY
| $3.58M | ﹤0.01% |
905,193
-751,061
| -45% | -$2.97M |
|
1298
Hanover Insurance
THG
$6.45B
| $3.58M | ﹤0.01% |
26,185
-22,605
| -46% | -$3.09M |
|
1299
Tenet Healthcare
THC
$17B
| $3.58M | ﹤0.01% |
94,067
-248,429
| -73% | -$9.45M |
|
1300
Pacific Biosciences
PACB
$360M
| $3.58M | ﹤0.01% |
695,814
+310,358
| +81% | +$1.6M |
|